Professor, Oncologic Sciences, USF-Morsani
Oncology
Dr. Ronald C. Deconti, MD
|
|
Give Review
Ronald C. Deconti, MD works in the field of Oncology. He researched medicine at Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care Ronald C. Deconti is a published doctor. He published 83 publications, including: 'Molecular staging of malignant melanoma: correlation with clinical outcome.'
Publications
- BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy.
- Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma.
- Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous Cell carcinoma.
- Squamous Cell carcinoma with rhabdoid phenotype of skin/soft tissue in a transplant patient: An exceptional case and review of the literature.
- Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma.
- The Tumor biology of melanoma nodal metastases.
- Phase II evaluation of Taxol in advanced head and neck Cancer: an Eastern Cooperative Oncology group trial.
- Hypersensitivity vasculitis associated with 2-deoxycoformycin and allopurinol therapy.
- Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes.
- Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of Malignant melanoma.
- Florida's undeclared epidemic: Malignant melanoma.
- Multiple primary melanomas: implications for screening and follow-up programs for melanoma.
- A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid Carcinoma.
- A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with m...
- Effective treatment of cutaneous and subcutaneous Malignant tumours by electrochemotherapy.
- Multimodality therapy of patients with locally advanced squamous cell Cancer of the head and neck: preliminary results of two pilot trials using paclitaxel and cisplatin.
- Molecular staging of Malignant melanoma: correlation with clinical outcome.
- Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid Tumors: a clinical and transla...
- Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
- Prognostic factors for survival after salvage reirradiation of head and neck Cancer.
- Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary Gland carcinoma.
- Systemic treatments for merkel Cell carcinoma.
- Changes in dendritic cell phenotype after a new high-dose weekly schedule of interleukin-2 therapy for kidney Cancer and melanoma.
- A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced Sarcoma.
- A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck Cancer.
- Response of psoriasis to N-phosphonacetyl-L-aspartate.
- Use of allopurinol for control of hyperuricemia in Leukemia and lymphoma.
- Cancer chemotherapy: current capabilities.
- Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic Disease.
- Correctable complications of neoplastic Disease. I. Hypercalcemia.
- Amenorrhea in patients with Hodgkin''s Disease treated with antineoplastic agents.
- Immunosuppression by 5-fluorouracil.
- Calabresi P: Treatment of polycythemia vera with azauridine and azaribine.
- The Yale combination chemotherapy program for advanced Hodgkin''s Disease. A preliminary report.
- Biochemical studies with 1 beta-D-arabinofuranosylcytosine in human leukemic leukocytes and normal bone marrow Cells.
- Procarbazine in the management of late Hodgkin''s Disease.
- Endotoxin stimulation in patients with Lymphoma: correlation with the myelosuppressive effects of alkylating agents.
- Abortifacient and teratogenic effects of triacetyl-6-azauridine in the monkey.
- Short-term sequential therapy with vinblastine (NSC-49842) and cyclophosphamide (NSC-26271) in Hodgkin''s Disease.
- Clinical and biochemical studies of high-dose intermittent therapy of solid Tumors with hydroxyurea (NSC-32065).
- Immunosuppressive effects of cytosine arabinoside and methotrexate in man.
- Treatment of advanced neoplastic Disease with 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037).
- Paralytic brachial neuritis in Hodgkin''s Disease.
- Clinical and pharmacological studies with 5-hydroxy-2-formylpyridine thiosemicarbazone.
- Combination sequential chemotherapy in advanced reticulum Cell sarcoma.
- Improved therapeutic index of methotrexate with "leucovorin rescue".
- Development of a combination chemotherapy program for adult Acute leukemia: CAM and CAM-L.
- Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).
- Comprehensive care of adult Acute leukemia.
- Treatment of Hodgkin''s disease and other Cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
- Effectiveness of high-dose infusions of methotrexate followed by leucovorin in Carcinoma of the head and neck.
- Continuous intravenous infusions of 5-fluoro-2''-deoxyuridine in the treatment of solid Tumors.
- Methotrexate therapy of head and neck Cancer: improvement in therapeutic index by the use of leucovorin "rescue".
- Chemotherapy of Cancer of the head and neck.
- Bleomycin therapy in advanced hodgkin''s disease and epidermoid Cancers.
- Survival following moderate-dose preoperative radiation therapy for Carcinoma of the rectum.
- Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced Head and neck cance...
- Clinical approach to neuroendocrine carcinoma of the skin (Merkel Cell carcinoma).
- Treatment of cutaneous and subcutaneous Tumors with electrochemotherapy using intralesional bleomycin.
- Final report of a phase II evaluation of paclitaxel in patients with advanced squamous Cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial...
- Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent Cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study.
- Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast Cancer.
- Phase I/II trial for the treatment of cutaneous and subcutaneous Tumors using electrochemotherapy.
- Accuracy of the subrenal capsule xenograft assay in predicting the clinical growth and chemosensitivity of human squamous head and neck Carcinomas.
- Growth and chemosensitivity of human head and neck Cancers implanted under the kidney capsule of cyclosporine-immunosuppressed mice.
- A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung Cancer.
- Long-term remission in diffuse histiocytic Lymphoma treated with combination sequential chemotherapy.
- Combination chemotherapy with cyclophosphamide (NSC-26271), cytosine arabinoside (NSC-63878), and methotrexate (NSC-740) in advanced solid Tumors.
- Phase II trial of sagopilone, a novel epothilone Analog in metastatic melanoma.
- Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic Malignant melanoma.
- Pharmacokinetic/pharmacodynamic Analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma.
- Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma.
- A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic Carcinoma of the head and ...
- A phase II trial of imatinib mesylate in merkel Cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331).
- Potentiation of a topoisomerase I inhibitor, karenitecin, by the histone deacetylase inhibitor valproic acid in melanoma: translational and phase I/II clinical trial.
- Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
- Phenotypic and functional Analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stim...
- Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous ...
- Survival after surgical resection of isolated pulmonary metastases from Malignant melanoma.
- Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck Cancer (E1395): an intergroup trial of the Ea...
- Phase II trial of karenitecin in patients with Malignant melanoma: clinical and translational study.
- Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous Cell carcinoma of the head and neck (E3395): a trial of the Eastern C...
Schools
Yale University School Of Medicine
Nc Meml Hospital University Nc
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Oncology
Accepted Insurances
- Accepts most major Health Plans. Please contact our office for details.
Education
-
Yale-New Haven Hospital -
University of North Carolina Hospitals -
Yale University School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Jeff S. Russell, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Khaldoun Almhanna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rand W. Altemose, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Scott J. Antonia, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Eduardo M. Sotomayor, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Trinidad Caintic, MD
This Doctor is OpenDoctor Recommended.
|